A measure of intratumor heterogeneity to predict metastasis and metastasis-free survival in patients with triple-negative breast cancer.

被引：0
|
作者：
Wang, Yucai
Yang, Fang
Wang, Yanru
Chang, Victor Tsu-Shih
Guan, Xiaoxiang
机构：
[1] Rutgers New Jersey Med Sch, Dept Med, Newark, NJ USA
[2] Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China
[3] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC USA
[4] VA New Jersey Hlth Care Syst, Hematol Oncol Sect, E Orange, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.1069
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1069
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Apalutamide and Metastasis-free Survival in Prostate Cancer
    Rachner, Tilman D.
    Tsourdi, Elena
    Hofbauer, Lorenz C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (26): : 2541 - +
  • [22] Characterizing mechanisms for inhibiting metastasis in triple negative breast cancer.
    Yang, Dongbo
    Dann, Christopher
    Pott, Sebastian
    Rosner, Marsha
    [J]. CANCER RESEARCH, 2020, 80 (21)
  • [23] CISH Expression Is Associated with Metastasis-Free Interval in Triple-Negative Breast Cancer and Refines the Prognostic Value of PDL1 Expression
    Boudin, Laurys
    De Nonneville, Alexandre
    Finetti, Pascal
    Guittard, Geoffrey
    Nunes, Jacques A.
    Birnbaum, Daniel
    Mamessier, Emilie
    Bertucci, Francois
    [J]. CANCERS, 2022, 14 (14)
  • [24] Modeling "decathlon winner" cancer cells that drive therapy resistance and metastasis in triple-negative breast cancer.
    Singh, Balraj
    Sarli, Vanessa N.
    Lucci, Anthony
    [J]. MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 49 - 50
  • [25] A potential prognostic long non-coding RNA signature to predict metastasis-free survival of breast cancer patients
    Sun, Jie
    Chen, Xihai
    Wang, Zhenzhen
    Guo, Maoni
    Shi, Hongbo
    Wang, Xiaojun
    Cheng, Liang
    Zhou, Meng
    [J]. SCIENTIFIC REPORTS, 2015, 5
  • [26] Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer
    Rouzier, R
    Pusztai, L
    Delaloge, S
    Gonzalez-Angulo, AM
    Andre, F
    Hess, KR
    Buzdar, AU
    Garbay, JR
    Spielmann, M
    Mathieu, MC
    Symmans, WF
    Wagner, P
    Atallah, D
    Valero, V
    Berry, DA
    Hortobagyi, GN
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (33) : 8331 - 8339
  • [27] A potential prognostic long non-coding RNA signature to predict metastasis-free survival of breast cancer patients
    Jie Sun
    Xihai Chen
    Zhenzhen Wang
    Maoni Guo
    Hongbo Shi
    Xiaojun Wang
    Liang Cheng
    Meng Zhou
    [J]. Scientific Reports, 5
  • [28] Response to Neoadjuvant Chemotherapy and Survival in Japanese Patients with Triple-Negative Breast Cancer.
    Ohtani, S.
    Kochi, M.
    Ito, M.
    Takada, S.
    Matsuura, H.
    Higaki, K.
    [J]. CANCER RESEARCH, 2011, 71
  • [29] Survival outcomes across ethnicities in triple-negative breast cancer.
    Rushton, Moira Katherine
    Zhang, Tinghua
    Song, Xinni
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [30] Effect of HER2-low status on brain metastasis-free survival and survival after brain metastasis in patients with breast cancer
    Onder, Tugba
    Karacin, Cengiz
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2024,
12345